EXECUTION COPY CONFIDENTIAL ASSET PURCHASE AGREEMENT By and Among PHIBRO ANIMAL HEALTH CORPORATION, as Purchaser MVP LABORATORIES, INC., as Company and together with MARY LOU CHAPEK and AVP, LLC, as Sellers January 12, 2016 Page ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 5th, 2020 • Nebraska
Contract Type FiledMay 5th, 2020 JurisdictionTHIS ASSET PURCHASE AGREEMENT (as the same shall be amended, modified or supplemented, this “Agreement”) dated January 12, 2016 (the “Effective Date”) by and between MVP Laboratories, Inc., a Nebraska corporation (“Company”), Mary Lou Chapek, an individual (“Principal Shareholder”), and AVP, LLC, a Nebraska limited liability company (“LLC”) and together with Company and Principal Shareholder, (“Sellers”), and Phibro Animal Health Corporation, a Delaware corporation (together with its permitted successors and assigns, “Purchaser”).
ASSET PURCHASE AGREEMENT By and Among PHIBRO ANIMAL HEALTH CORPORATION, as Purchaser MVP LABORATORIES, INC., as Company and together with MARY LOU CHAPEK and AVP, LLC, as Sellers January 12, 2016Asset Purchase Agreement • May 9th, 2016 • Phibro Animal Health Corp • Pharmaceutical preparations • Nebraska
Contract Type FiledMay 9th, 2016 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (as the same shall be amended, modified or supplemented, this “Agreement”) dated January 12, 2016 (the “Effective Date”) by and between MVP Laboratories, Inc., a Nebraska corporation (“Company”), Mary Lou Chapek, an individual (“Principal Shareholder”), and AVP, LLC, a Nebraska limited liability company (“LLC”) and together with Company and Principal Shareholder, (“Sellers”), and Phibro Animal Health Corporation, a Delaware corporation (together with its permitted successors and assigns, “Purchaser”).